Institutional investors purchased a net $2.1 million shares of EXAS during the quarter ended September 2016 and now own 87.43% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
HIGHMARK CAPITAL MANAGEMENT, INC... Bought 31.8 Thousand shares of Exact Sciences Corp